Sponsors

Screening for Cryptosporidium/Giardia by EIA

Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect. Similarly, Giardia infection is frequently misdiagnosed, relying on poorly performing antigen-based testing.

Pro-Lab Diagnostics’ Prolisa Cryptosporidium/Giardia enzyme immunoassay (EIA) is a convenient, rapid and easy-to-use method for detecting Cryptosporidium and Giardia lamblia. Supplied in a 96-well test size consisting of detachable stripwells, this manual assay uses monoclonal anti-Cryptosporidium and anti-G. lamblia antibodies to ensure excellent sensitivity and specificity for high-value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility.

Mark Reed, General Manager of Pro-Lab Diagnostics, commented: “The Cryptosporidium/Giardia EIA is an important part of the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for cryptosporidiosis and giardiasis, with the back-up support of our team of application experts.”
www.pro-lab.com

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025